enGene Therapeutics Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jul 2026Filed 08/09/2026 | Apr 2026Filed 08/09/2026 | Jan 2026Filed 08/09/2026 | Jul 2025Filed 08/09/2026 | Apr 2025Filed 08/09/2026 | Jan 2025Filed 08/09/2026 | Jul 2024Filed 11/09/2025 | Apr 2024Filed 11/09/2025 |
|---|---|---|---|---|---|---|---|---|
| −$33 | −$30 | −$30 | −$29 | −$26 | −$25 | −$14 | −$15 | |
| −$0.47 | −$0.43 | $0.44 | −$0.57 | −$0.51 | $0.48 | $0.32 | $0.38 | |
| 70 | 70 | 67 | 51 | 51 | 51 | 44 | 39 |
Trend